Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Increase (Decrease) in Accrued Liabilities

Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Accrued Liabilities of $21.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06

  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.99M.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $23.00M, a 591.23% increase year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $19.85M, a 29.70% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$26.31M, a 1553.76% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$9.08M, a 119.42% decline from fiscal 2024.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $46.77M.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$81.11M, a 227.59% decline from fiscal 2022.
  • Lantheus Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $63.58M, a 293.78% increase from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities 12 month as first filed
2026-06-30-$1.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$21.02M
10-Q · filed 2026-08-06
$40.87M
derived: sum of 3 quarters · filed 2026-08-06
$14.55M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$23.00M
10-Q · filed 2026-05-07
$42.85M
derived: sum of 2 quarters · filed 2026-05-07
$16.54M
derived: sum of 3 quarters · filed 2026-05-07
$10.59M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$19.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$6.46M
derived: sum of 2 quarters · filed 2026-02-26
-$12.41M
derived: sum of 3 quarters · filed 2026-08-06
-$9.08M
10-K · filed 2026-02-26
2025-09-30-$26.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$32.26M
derived: sum of 2 quarters · filed 2026-08-06
-$28.93M
10-Q · filed 2025-11-06
-$694.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$5.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$2.62M
10-Q · filed 2026-08-06
$25.62M
derived: sum of 3 quarters · filed 2026-08-06
$27.43M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$3.33M
10-Q · filed 2026-05-07
$31.57M
derived: sum of 2 quarters · filed 2026-05-07
$33.38M
derived: sum of 3 quarters · filed 2026-05-07
-$354.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$28.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$30.05M
derived: sum of 2 quarters · filed 2026-02-26
-$3.68M
derived: sum of 3 quarters · filed 2026-02-26
$46.77M
10-K · filed 2026-02-26
2024-09-30$1.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$31.92M
derived: sum of 2 quarters · filed 2025-11-06
$18.53M
10-Q · filed 2025-11-06
$26.61M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$33.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$16.72M
10-Q · filed 2025-08-06
$24.80M
derived: sum of 3 quarters · filed 2026-02-26
$47.61M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$50.45M
10-Q · filed 2025-05-07
$58.53M
derived: sum of 2 quarters · filed 2026-02-26
$81.34M
derived: sum of 3 quarters · filed 2026-02-26
-$42.47M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$8.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$30.89M
derived: sum of 2 quarters · filed 2026-02-26
-$92.92M
derived: sum of 3 quarters · filed 2026-02-26
-$81.11M
10-K · filed 2026-02-26
2023-09-30$22.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$101.00M
derived: sum of 2 quarters · filed 2024-11-06
-$89.20M
10-Q · filed 2024-11-06
-$55.99M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$123.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$112.00M
10-Q · filed 2024-07-31
-$78.80M
derived: sum of 3 quarters · filed 2025-02-26
-$71.79M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$11.80M
10-Q · filed 2024-05-02
$45.00M
derived: sum of 2 quarters · filed 2025-02-26
$52.01M
derived: sum of 3 quarters · filed 2025-02-26
$76.41M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$33.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$40.21M
derived: sum of 2 quarters · filed 2025-02-26
$64.61M
derived: sum of 3 quarters · filed 2025-02-26
$63.58M
10-K · filed 2025-02-26
2022-09-30$7.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$31.41M
derived: sum of 2 quarters · filed 2023-11-02
$30.37M
10-Q · filed 2023-11-02
$42.58M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$24.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$23.36M
10-Q · filed 2023-08-03
$35.57M
derived: sum of 3 quarters · filed 2024-02-22
$39.49M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$1.04M
10-Q · filed 2023-05-04
$11.17M
derived: sum of 2 quarters · filed 2024-02-22
$15.09M
derived: sum of 3 quarters · filed 2024-02-22
$21.73M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$12.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$16.13M
derived: sum of 2 quarters · filed 2024-02-22
$22.77M
derived: sum of 3 quarters · filed 2024-02-22
$16.14M
10-K · filed 2024-02-22
2021-09-30$3.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$10.56M
derived: sum of 2 quarters · filed 2022-11-03
$3.94M
10-Q · filed 2022-11-03
$6.51M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$6.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$14.00K
10-Q · filed 2022-08-04
$2.59M
derived: sum of 3 quarters · filed 2023-02-23
$3.88M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$6.62M
10-Q · filed 2022-04-29
-$4.05M
derived: sum of 2 quarters · filed 2023-02-23
-$2.76M
derived: sum of 3 quarters · filed 2023-02-23
-$3.49M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$2.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$3.86M
derived: sum of 2 quarters · filed 2023-02-23
$3.13M
derived: sum of 3 quarters · filed 2023-02-23
-$4.16M
10-K · filed 2023-02-23
2020-09-30$1.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$554.00K
derived: sum of 2 quarters · filed 2021-11-04
-$6.74M
10-Q · filed 2021-11-04
-$2.90M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$733.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
-$8.02M
10-Q · filed 2021-07-28
-$4.18M
derived: sum of 3 quarters · filed 2022-02-24
$3.87M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$7.29M
10-Q · filed 2021-05-04
-$3.45M
derived: sum of 2 quarters · filed 2022-02-24
$4.60M
derived: sum of 3 quarters · filed 2022-02-24
$6.63M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$11.89M
derived: sum of 2 quarters · filed 2022-02-24
$13.92M
derived: sum of 3 quarters · filed 2022-02-24
$6.08M
10-K · filed 2022-02-24
2019-09-30$8.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$10.09M
derived: sum of 2 quarters · filed 2020-11-05
$2.24M
10-Q · filed 2020-11-05
$2.02M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$2.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$5.82M
10-Q · filed 2020-07-31
-$6.04M
derived: sum of 3 quarters · filed 2021-02-25
-$899.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$7.85M
10-Q · filed 2020-04-30
-$8.07M
derived: sum of 2 quarters · filed 2021-02-25
-$2.93M
derived: sum of 3 quarters · filed 2021-02-25
$59.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$220.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$4.92M
derived: sum of 2 quarters · filed 2021-02-25
$7.91M
derived: sum of 3 quarters · filed 2021-02-25
$2.25M
10-K · filed 2021-02-25
2018-09-30$5.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$8.13M
derived: sum of 2 quarters · filed 2019-10-31
$2.47M
10-Q · filed 2019-10-31
$4.73M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$2.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
-$2.67M
10-Q · filed 2019-07-25
-$409.00K
derived: sum of 3 quarters · filed 2020-02-25
$1.13M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$5.66M
10-Q · filed 2019-04-30
-$3.40M
derived: sum of 2 quarters · filed 2020-02-25
-$1.85M
derived: sum of 3 quarters · filed 2020-02-25
$2.04M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$2.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$3.80M
derived: sum of 2 quarters · filed 2020-02-25
$7.69M
derived: sum of 3 quarters · filed 2020-02-25
$4.50M
10-K · filed 2020-02-25
$4.53M
10-K · filed 2018-02-26
2017-09-30$1.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$5.43M
derived: sum of 2 quarters · filed 2018-10-30
$2.24M
10-Q · filed 2018-10-30
$970.00K
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30$3.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$694.00K
10-Q · filed 2018-08-01
-$573.00K
derived: sum of 3 quarters · filed 2019-02-20
$3.91M
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31-$3.20M
10-Q · filed 2018-05-02
-$4.46M
derived: sum of 2 quarters · filed 2019-02-20
$16.00K
derived: sum of 3 quarters · filed 2019-02-20
$2.84M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31-$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
$3.21M
derived: sum of 2 quarters · filed 2019-02-20
$6.04M
derived: sum of 3 quarters · filed 2019-02-20
$1.23M
10-K · filed 2019-02-20
$1.34M
10-K · filed 2017-02-23
2016-09-30$4.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$7.30M
derived: sum of 2 quarters · filed 2017-11-02
$2.50M
10-Q · filed 2017-11-02
$2.51M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$2.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$1.98M
10-Q · filed 2017-08-01
-$1.97M
derived: sum of 3 quarters · filed 2018-02-26
$747.00K
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$4.81M
10-Q · filed 2017-05-02
-$4.57M
10-Q · filed 2016-05-03
-$4.80M
derived: sum of 2 quarters · filed 2018-02-26
-$2.08M
derived: sum of 3 quarters · filed 2018-02-26
-$14.04M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$2.73M
derived: sum of 2 quarters · filed 2018-02-26
-$9.23M
derived: sum of 3 quarters · filed 2018-02-26
-$3.99M
10-K · filed 2018-02-26
2015-09-30$2.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
-$9.25M
derived: sum of 2 quarters · filed 2016-11-01
-$4.00M
10-Q · filed 2016-11-01
-$14.85M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30-$11.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$6.71M
10-Q · filed 2016-08-04
-$17.57M
derived: sum of 3 quarters · filed 2017-02-23
-$8.02M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$5.25M
10-Q · filed 2016-05-03
-$5.60M
derived: sum of 2 quarters · filed 2017-02-23
$3.95M
derived: sum of 3 quarters · filed 2017-02-23
2014-12-31-$10.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$1.30M
derived: sum of 2 quarters · filed 2017-02-23
-$4.94M
10-K · filed 2017-02-23
2014-09-30$9.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$5.92M
10-Q · filed 2015-11-04
2014-06-30-$3.63M
10-Q · filed 2015-08-05
2013-12-31-$9.63M
10-K · filed 2016-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B